21180 ⎘
Medicinal preparations containing antigens or antibodies characterised by the route of administration; Mucosal route oral/gastrointestinal
vectored vaccines against and methods of use
#602SINGLE-TIME VACCINES
#603VEHICLE FOR DELIVERING A COMPOUND TO A MUCOUS MEMBRANE AND RELATED COMPOSITIONS, METHODS AND SYSTEMS
#604Soft gel delivery system for treating poultry
#605Avian Influenza Virus Antigen, and Booster Immunization Method for Avian Influenza Vaccine in Combination with Mucosal Adjuvant Which is Effective Through Oral Administration
#606Enterovirus type 71 protein and method for production
#607COMPOSITIONS AND METHODS FOR TREATING HEPATITIS A
#608Oral recombinant vaccine and preparing method thereof
#609Vaccines for inclusion body hepatitis
#610Rabies virus-based recombinant immunocontraceptive compositions and methods of use
#611Methods of Modulating Immunity
#612Method and composition for delivery of medicants to animals
#613METHOD AND COMPOSITION FOR DELIVERY OF MEDICANTS TO ANIMALS
#614MUCOADHESIVE PARTICULATE FORMULATION FOR INDUCING ANTIGEN-SPECIFIC IMMUNE TOLERANCE
#615REDUCED COLONIZATION OF MICROBES AT THE MUCOSA
#616Mucosomal allergen-specific immunotherapy with initial dosing after start of pollen season
#617antigens, vaccine compositions, and related methods
#618Fermentation process
#619Mucosal membrane receptor and uses thereof
#620Adenoviral-based vectors
#621Swine influenza hemagglutinin variants
#622POTENT MUCOSAL IMMUNE RESPONSE INDUCED BY MODIFIED IMMUNOMODULATORY OLIGONUCLEOTIDES
#623Mutated strain and use thereof in a vaccine
#624Production of OspA for Lyme Disease Control
#625Methods, compositions and kits for vegetative cell-based vaccines and spore-based vaccines
#626COMPOSITIONS AND METHODS FOR TREATING INFLUENZA
#627Transmucosal administration of aggregated antigens
#628VACCINE COMPOSITIONS AND USES THEREOF
#629NOVEL VACCINE FOR DOG
#630SCREENING METHOD FOR PREDICTING SUSCEPTIBILITY TO BREAST CANCER
#631Process and formulation for immunizing fish in aquaculture systems
#632Treatment and prevention of tuberculosis
#633MULTI EPITOPE VACCINE FOR POULTRY
#634Production of Foreign Nucleic Acids and Polypeptides in Sprout Systems
#635Tannin-chitosan composites
#636Plant vector pBSNB-TEV, vectors derived therefrom, and methods of use
#637Recombinant Double-Stranded RNA Phage, and Use of the Same
#638VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARS
#639Single cycle replicating adenovirus vectors
#640Carbon nanotube compositions and methods of use thereof
#641Screening method for predicting susceptibility to breast cancer
#642for dust mite allergy
#643SOLID DISPERSING VACCINE COMPOSITION FOR ORAL DELIVERY
#644Oral delivery of tetanus toxoid
#645Antigen-norovirus P-domain monomers and dimers, antigen-norovirus P-particle molecules, and methods for their making and use
#646EXPRESSION CASSETTE, T-DNA MOLECULE, PLANT EXPRESSION VECTOR, TRANSGENIC PLANT CELL AS WELL AS THEIR USE IN THE MANUFACTURING OF A VACCINE
#647Immunotherapy and prevention of autoimmune hepatitis
#648Orally bioavailable lipid-based constructs
#649Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof
#650Anti-estrogen and immune modulator combinations for treating breast cancer
#651High Molecular Weight Amyloid Beta As a Carrier for the Oral Delivery of Vaccine Antigens
#652Inactivated bacterial cell formulation
#653ALLERGY VACCINE COMPOSITION FOR MUCOSAL ADMINISTRATION
#654PHARMACEUTICAL COMPOSITION FOR THE SUBLINGUAL ADMINISTRATION OF VACCINES, METHOD FOR THE PREPARATION OF THE SAME AND USES THEREOF
#655Adjuvant composition for vaccine
#656PHARMACEUTICAL FORMULATION FOR ALLERGEN PREPARATION
#657Breast cancer eradication program
#658Plant-Derived Cholera and Malaria Vaccine
#659VACCINE COMPOSITION COMPRISING AN IMMUNOADJUVANT COMPOUND CONSISTING OF A RHO GTPASE FAMILY ACTIVATOR
#660Vaccine against
#661Orally bioavailable lipid-based constructs
#662Formulations for preservation of rotavirus
#663Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
#664METHODS AND COMPOSITIONS OF TREATMENT FOR MODULATING THE IMMUNE SYSTEM OF ANIMALS
#665Oral vaccination
#666Use of coccidian
#667Antibodies for preventing and treating attaching and effacing (AEEC) associated diseases
#668Method of inducing immune tolerance to type I diabetes
#669Method of reducing phosphate absorption by administering orally an IgY anti-intestinal sodium phosphate cotransporter type 2B antibody
#670Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates
#671METHODS OF PREDICTING CANCER LETHALITY USING REPLIKIN COUNTS
#672Enterovirus type 71 protein and method for production
#673Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections
#674BIFIDOBACTERIUM IN THE TREATMENT OF INFLAMMATORY DISEASE
#675Nanospheres encapsulating bioactive material and method for formulation of nanospheres
#676Compositions produced using enteric pathogens and methods of use
#677TREATMENT OF IMMUNE DISEASE BY MUCOSAL DELIVERY OF ANTIGENTS USING GENETICALLY MODIFIED LACTOBACILLUS
#678Antigenicity of infectious pancreatic necrosis virus VP2 sub-viral particles expressed in yeast
#679INFLUENZA VACCINE
#680Carrier
#681Stabilized liquid rotavirus vaccine composition
#682Procedure For Expressing A Tbpb Protein On The Bacterial Surface Of An Attenuated Oral Live Vaccine As Prototype Of A Meningitis B Vaccine
#683Novel Vaccination Carrier
#684METHODS OF VACCINE ADMINISTRATION
#685Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals
#686Processes for treating subjects carrying viral infectious agent
#687Uses for Yerba Santa
#688Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic
#689Methods for stimulating an immune response using bacterial antigen delivery system
#690Method for The Production of Hydrolyzed Allergen
#691Vaccine for disease and streptococcal disease in fish
#692Oral vaccines
#693Recombinant double stranded RNA nucleocapsid and use of the same
#694Vaccine comprising recombinant ct or lt toxin
#695Use of a Liquid Allergy Vaccine Formulation for Oromucosal Administration
#696based oral vaccines for anthrax
#697Chloroplast-derived human vaccine antigens against malaria
#698Prevention of allergy in children
#699RECOMBINANT VACCINE AGAINST JAPANESE ENCEPHALITIS VIRUS (JEV) INFECTION AND A METHOD THEREOF
#700DNA COMPOSITION FOR ELICITING AN IMMUNE RESPONSE AGAINST TUMOR-ASSOCIATED MACROPHAGES
#701TARGETED AND HIGH DENSITY DRUG LOADED POLYMERIC MATERIALS
#702METHODS AND COMPOUNDS FOR MITIGATING PATHOGENIC OUTBREAKS USING REPLIKIN COUNT CYCLES
#703METHODS OF TREATMENT WITH DRUG LOADED POLYMERIC MATERIALS
#704Encapsulated vaccines for the oral vaccination and boostering of fish and other animals
#705Viral vaccine composition, process and methods of use
#706Cloned defective interfering influenza A virus
#707RECOMBINANT LACTOBACILLUS AND USE OF THE SAME
#708Solid Vaccine Formulation
#709Induction of mucosal tolerance to antigens
#710Bioactive copepod-compositions, processes for the production thereof, and use thereof to prevent or treat hosts infested by phylogenetically similar ectoparasites
#711Homogeneous attenuated human rotavirus population
#712Compositions and methods for stimulating an immune response against infectious agents
#713Mucosal vaccine enabling switching from production of IgA antibody to production of both of IgA and IgG antibodies
#714Transgenic algae for delivering antigens to an animal
#715Antibodies for preventing and treating attaching and effacing (AEEC) associated diseases
#716Colonization factor (CF) antigens of enterotoxigenic escherichia coli in recombinant bacteria
#717Immunomodulator Compounds as Vaccine Enhancers
#718Compositions and methods for transepithelial molecular transport
#719IMMUNE RESPONSE ENHANCING GLUCAN
#720Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
#721RETROVIRAL IMMUNOTHERAPY
#722Rotavirus Vaccine Inducing Heterotypic Cross Protection
#723Bacterial delivery of biologically active polypeptides
#724Human papillomavirus vaccine for oral administration
#725MEDICINAL FORMULATION FOR THE TREATMENT FOR HEPATITIS C
#726Peroral Vaccine Carrier System
#727Therapy-enhancing glucan
#728Pharmaceutical preparation that can be administered orally for treating fish, production method for said preparation and use of the latter
#729Vaccines for diseases of fish
#730BIFIDOBACTERIUM IN THE TREATMENT OF INFLAMMATORY DISEASE
#731ORAL PERTUSSIS VACCINE AND METHOD FOR PRODUCING PERTUSSIS VACCINE
#732Immunogenical complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica
#733Live attenuated bacterial vaccine to reduce or inhibit carriage and shedding of enterohemorrhagic in cattle
#734Chloroplasts Engineering to Express Pharmaceutical Proteins
#735Oral Vaccines for Fish
#736Pharmaceutical Composition Comprising a Bacterial Cell Displaying a Heterologous Proteinaceous Compound
#737Vaccination against multiple serotypes of pasteurella multocida
#738VACCINATION OF HORSES AGAINST LAWSONIA INTRACELLULARIS
#739Compositions for antigen-specific induction of tolerance
#740Immunoactive Compositions for Improved Oral Delivery of Vaccines and Therapeutic Agents
#741Method and composition for delivery of medicants to animals
#742BREAST CANCER ERADICATION PROGRAM
#743METHODS AND COMPOSITIONS FOR TREATMENT OF IMMUNE DYSFUNCTION DISORDERS
#744Allergen dosage form
#745Soft gel delivery system for treating poultry
#746Allergen dosage form
#747Recombinant HBsAg virus-like particles containing polyepitopes of interest, their production and use
#748Polynucleotides allowing the expression and secretion of recombinant HBsAg virus-like particles containing a foreign peptide, their production and use
#749Live attenuated rotavirus vaccine for oral administration
#750Methods of treating multiple myeloma using combination therapies based on anti-CS1 antibodies
#751METHODS AND COMPOSITIONS FOR MODULATING THE IMMUNE SYSTEM OF ANIMALS
#752LIVE BACTERIAL VACCINES FOR VIRAL INFECTION PROPHYLAXIS OR TREATMENT
#753METHOD FOR INDUCING MUCOSAL HUMORAL AND CELL-MEDIATED IMMUNE RESPONSES BY SUBLINGUAL ADMINISTRATION OF ANTIGENS
#754strains VCUSM1 and VCUSM4, method of producing same, and vaccine derivatives thereof
#755Feline influenza vaccine and method of use
#756Immunological combination compositions and methods
#757VACCINE
#758Bifidobacterium in the treatment of inflammatory disease
#759Immunogenic composition of a homogeneous live attenuated human rotavirus population
#760JC Virus Vaccine
#761METHODS FOR PREPARING AND DELIVERING ADJUVANT COMPOSITIONS
#762Yeast Cell Particles As Oral Delivery Vehicles For Antigens
#763PREVENTION OF ALLERGY IN CHILDREN
#764HIV immunogenic composition and method of administration
#765Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factors
#766SOLID DISPERSING VACCINE COMPOSITION FOR ORAL DELIVERY
#767Methods of treatment with drug loaded polymeric materials
#768Methods for conferring immunity against protozoans in an animal
#769Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin
#770Antigen-containing microspheres for the treatment of allergies
#771Influenza antigens, vaccine compositions, and related methods
#772RECOMBINANT FRAGMENTS OF THE HUMAN ACETYLCHOLINE RECEPTOR AND THEIR USE FOR TREATMENT OF MYASTHENIA GRAVIS
#773SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING PREGABALIN
#774Recombinant Vaccine Against Japanese Encephalitis Virus (Jev) Infection and a Method Thereof
#775Method for Determining Dosage for an Oral Killed Vaccine
#776Cold-adapted equine influenza viruses
#777Anthrax vaccines and delivery methods
#778EDIBLE VACCINE
#779Hot melt coating by direct blending and coated substrates
#780Bifidobacterium in the treatment of inflammatory disease
#781system and uses thereof
#782Orally-administered live bacterial vaccines for plague
#783Mucosal immunization to prevent prion infection
#784DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof
#785Vectors based on recombinant defective viral genomes and their use in the formulation of vaccines
#786Coccidial vaccine and methods of making and using same
#787Receptor specific transepithelial transport of therapeutics
#788Lawsonia vaccine and methods of use thereof
#789Gene expression vaccine
#790Use of lactobacillus salivarius
#791Production of foreign nucleic acids and polypeptides in sprout systems
#792Recombinant double-stranded RNA phage, and use of the same
#793Treating gastrointestinal diseases with modulators of retinoic acid
#794Recombinant nucleic acid useful for inducing protective immune response against allergens
#795Inactivated vibrio cholerae vaccine in tablet form
#796Use of HIV-1 gp120 and gp160 proteins modified in the V3 loop for the preparation of vaccine compositions and formulations containing the same
#797Oral DNA composition for hepatitis B virus chronic infection
#798Immunogenic compositions comprising
#799Oral administration of therapeutic agent coupled to transporting agent induces tolerance
#800Method of preventive treatment of allergy by oromucosal administration of an allergy vaccine
#801Methods and composition for oral vaccination
#802Use of inactive immunosuppressive and/or angiogenic immunogenic proteins, for producing secretory IgA's
#803Inactivated influenza virus vaccine for nasal or oral application
#804Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin
#805Recombinant double-stranded RNA phages and uses thereof
#806Trivalent vaccine with maternal anitbody transfer via the milk
#807Methods for inducing an immune response via oral administration of an adenovirus
#808Oral drug delivery compositions and methods
#809Viruses and virus-like particles for multiple antigen and target display
#810Protein and peptide expression for passive immunity
#811Liquid allergy vaccine formulation for oromucosal administration
#812Immunological combination compositions and methods
#813Vibrio cholerae strains VCUSM1 and VCUSM4, method of producing same, and vaccine derivatives thereof
#814Use of passive myostatin immunization in egg laying vertebrates
#815Compositions against chicken coccidiosis
#816Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS
#817Advanced oral poliovirus vaccine (Adv-OPV) deprived of the possibility of vaccine associated paralytic poliomyelities (VAPP)
#818Methods of treatment with drug loaded polymeric materials
#819Method of treating allergy and infection by eliciting an IGA antibody response
#820Bifidobacterium in the treatment of inflammatory disease
#821Targeted and high density drug loaded polymeric materials
#822Vaccination of skunks and/or mongooses against rabies
#823Feed for fish and shellfish, additive therefor, and method for producing additive
#824Method of making microalgal-based animal foodstuff supplements, microalgal-supplemented animal foodstuffs and method of animal nutrition
#825Novel therapeutic processes for treating infectious agents using same epitope specific antigens, and useful compositions therefor
#826Methods and compositions for modulating the immune system of animals
#827Novel therapeutic processes for treating cancer with trained or adopted immune cells, and useful compositions therefor
#828Use of vitelline protein B as a microencapsulating additive
#829Novel therapeutic processes for treating cancer with specific antigens
#830Novel therapeutic processes for treating infectious agents by training or adoptive transfer of immune cells, and useful compositions therefor
#831Novel therapeutic processes for enhancing immunized states of vaccinated subjects
#832Vaccines expressed in plants
#833Bacterial spores
#834Oral vaccination
#835Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
#836Bifidobacterium in the treatment of inflammatory disease
#837Method of evaluating the therapeutic potential of a vaccine for mucosal administration
#838Inactivated influenza virus vaccine for nasal or oral application
#839Methods of modulating immunity
#840DNA immunocontraceptive vaccines and uses thereof
#841Coccidial vaccine and methods of making and using same
#842Compositions produced using enteric pathogens and methods of use
#843Pharmaceutical composition for administration to mucosal surfaces
#844Methods and compositions for dosing of allergens
#845Immunogenic compositions and methods of use thereof
#846Adjuvant composition comprising FHA protein or a fragment of FHA protein in its free form
#847Vectors and methods for immunization against norovirus using transgenic plants
#848Therapeutic processes and useful compositions therefor
#849Novel therapeutic vaccination processes, and useful compositions therefor
#850Novel therapeutic processes for establishing or enhancing an immunized state, and compositions useful therefor
#851Oral vaccine, method for its preparation and use thereof
#852Bacterial vectors and methods of use thereof
#853Expression of protective antigens in transgenic chloroplasts
#854polypeptides and methods of use
#855Feed for fish and shellfish, additive therefor, and method for producing additive
#856Use of lactobacillus salivarius
#857Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
#858Bifidobacterium in the treatment of inflammatory disease
#859Mycobacterium avium subspecies paratuberculosis oral vaccine and methods
#860Immunization with an attenuated human rotavirus
#861Microencapsulated DNA for vaccination and gene therapy
#862Method and compositions for treatment of insulin-dependant diabetes mellitus
#863SARS-coronavirus virus-like particles and methods of use
#864Oral vaccine for peste-des-petits-ruminants virus
#865Pathogen specific avian antibodies in the neonatal mammal